EUVIMED · CrossrefZeitschrift
Expert Review of Gastroenterology & Hepatology
ISSN 1747-4124 · Informa UK Limited
Neueste Artikel
Recent recommendations for the diagnosis and management of liver cirrhosis and its complications
Current evidence of real-world experience with resmetirom in clinical practice in the United States: a targeted literature review
Various applications of lumen apposing metal stents in challenging gastrointestinal, and pancreaticobiliary cases
Rome V criteria for pediatric disorders of gut–brain interaction: key updates and clinical implications
Anti-fibrotic therapy in Crohn’s disease: hype or reality—can intestinal fibrosis be targeted effectively?
Short bowel syndrome-associated intestinal failure: diagnosis and prognosis
Clinical role of anti-PD-1 immunotherapies in esophageal cancer
Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease – paving a path forward
Functional imaging: a game changer for biomarker discovery and treatment response among patients with hepatocellular carcinoma
Measuring gut microbiome as a colorectal cancer screening tool: potential and challenges
Impact of GLP-1 receptor agonists on gastrointestinal function and symptoms
Extra-intestinal manifestations in inflammatory bowel disease: a comparative review of pediatric and adult-onset disease
Non-invasive biomarkers of gastric function from body surface gastric mapping and their role in chronic gastroduodenal disorders
Gut microbial healing in IBD: visionary approach or evidence-based reality?
Advancements in the prevention and management of postoperative Crohn’s disease recurrence
Recent developments in managing luminal microbial ecology in patients with inflammatory bowel disease: from evidence to microbiome-based diagnostic and personalized therapy
Living donor liver transplant for alcohol-associated hepatitis: considerations and global perspectives
Migration of surgical clips into the biliary tree - the potential for cholangioscopy
Revolutionizing liver fibrosis research: the promise of 3D organoid models in understanding and treating chronic liver disease
Dupilumab is efficacious for eosinophilic esophagitis irrespective of prior swallowed budesonide or fluticasone, or prior treatments used alongside swallowed topical corticosteroids: results from the phase 3, randomized, placebo-controlled, LIBERTY EoE TREET trial
Gut microbiota: the pathogenetic bridge between inflammatory bowel disease and metabolic-associated steatotic liver disease
Antibiotics in decompensated liver disease – who, when and for how long?
The assessment of impaired liver function and prognosis in hepatocellular carcinoma
UK medical cannabis registry: an updated analysis of clinical outcomes of cannabis-based medicinal products for inflammatory bowel disease
Overcoming the effects of increasing antimicrobial resistance on Helicobacter pylori therapy
Colonic diverticular disease revisited
Metabolites derived from gut microbiota mitigate chemoresistance in pancreatic cancer
Esophageal lymphocytosis: exploring the knowns and unknowns of this pattern of esophageal injury
Recent advances in treating constipation in children
From NAFLD to MASLD: what does it mean?
EUVIMED